| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $72.5M | -4.7% |
| Cost of Revenue | $40.4M | -21.9% |
| Gross Profit | $32.1M | +32.1% |
| R&D Expense | $38.5M | +3.5% |
| SG&A Expense | $33.2M | +19.5% |
| Operating Income | -$39.5M | +2.6% |
| Pre-tax Income | -$36.4M | +8.1% |
| Income Tax | $40K | +42.9% |
| Net Income | -$36.5M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $140.3M | +130.0% |
| Accounts Receivable | $7.3M | -29.9% |
| Inventory | $16.9M | +12.9% |
| Current Assets | $167.9M | +88.8% |
| Total Assets | $184.7M | +77.1% |
| Current Liabilities | $19.2M | +63.0% |
| Total Liabilities | $22.2M | +19.9% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$19.7M | +8.1% |
| Investing Cash Flow | -$7.4M | -99.5% |
| Financing Cash Flow | $106.4M | +80.8% |
| +8.1% |
| EPS (Basic) | -$4.57 | +96.0% |
| EPS (Diluted) | -$4.57 | +96.0% |
| Stockholders' Equity |
| $162.5M |
| +155.6% |